1FDA controls
prescription drugs
Over the counter medications
Brand name (patented) drug vs generic drugs
2Label information
approved by ____
available ______
contains in standard format the …
____ a critical guide to appropriate use in medicine: lack of studies of _______ ______
FDA
online
chemistry, pharmacokinetics, indication, mechanism, side effects, toxicity, contraindications, dosage, information for special populations
NOT, comparative efficacy
3Impact of label indication
illegal to ship or promote drug for other than ______ ___________
prescriber may use ____ _______ inidcation
label indications can change as
label indication
off label
new data is obtained
4Pharmacokinetics
how drugs reach targets in the body
what determines the change with time of the concentration at target sites
5absorption
from administration site into the blood stream
6distribution
from blood stream into tissues
Cp - concentration in plasma
7elimination
from body
by metabolism or to other molecules
by excretion in urine, feces, air
8Filtration
through porosites between cells
transport in bulk flow of aqueous fluid
9rate of filtration dependent on
hydrostatic pressure
molecular size
binding to plasma proteins that prevents filtration
tissue porosity
10passive diffusion - what?
important in cellular structures with _____ ______ and lack of ____
through cell membranes into and out of cells
lipid of plasma membrane
tight junctions, porosity
11rate of passive diffusion dependent on
concentration gradient
MW
Lipophilicity
12Lipophilicity
solubility in lipid relative to water
measured by oil/water parition coefficient
predicts permeation into cells and accumulation in fat
13carrier mediated transport
across cell membranes into and out of cells, uses transport proteins
14absorption kinetics characterized by
absorption half life - how fast
percent dose absorbed - bioavailability - how much
15first pass effect
degradation by enzyms in GI lumen. mucosa, or liver
why some drugs have poor bioavailability through oral route
16Apparent volume of distribution
Vd
Volume of blood into which a drug appears to have distributed
dilutes dose to produce a concentration
17Elimination kinetics
quantified by _________
rate and extent of elimination by (2)
clearance
excretion of body or metabolism into another molecule
18Total Clearance CIt
volume of plasma cleared of compount per unit time by all routes and mechanisms
expressed as ml/min or ml/hr normalized for body weight
sum of renal and non renal clearances
CIt = CIrenal + CInonrenal
19Biotransformation 3 types
inactive
active
toxic
20inactive
they don’t interact with target
21active
turns into a molecule with similar activity, so eliminated but still has an effect
22toxic
bad
ex: acetaminophen -> liver toxicity
23Elimination half life
time to eliminate 50% of drug from plasma
generally independent of dose
slower clearance = longer half life
24loading dose
may be higher at first in order to achieve steady state
or if you need a rapid onset of effect
25Targets of Drug Action
Receptors
Transporters
Enzymes
DNA
mRNA
26Types of Receptors
Transcription factor
enzyme
Ion channel
G protein coupled
27Nontherapeutic Effects
Excessive therapeutic effect
side effects
toxic effect
adverse drug reactions
allergic reactions
Idiosyncratic reactions - not a side effect yet bc it only happens to a few people
28Specificity
ability to produce effects by one mechanism
29Selectivity
ability to produce one effect such as the desired therapeutic effect without producig other effects
the most selective drug is the safest one
30maximum efficacy
intensity of the drug measured in relation to its concentration
31EC50 reflects the drugs
binding affinity
32Drug concentration effect relationship
intensity of a drug increases with its concentration until the Emax is achieved
The concentration that produces 50% of Emax, the EC50 is determined by the drug’s affinity for binding to the target
33the less amount needed, lowest EC50 =
highest potency
34drugs that act on the same target may differ in their
maximum efficacy
35antagonists
agents with affinity for a receptor but without effiacy
bind but has no effect -> inhibitors
like a beta blocker
36antagonists interactions usually
reversible and competitive
compete for the same binding sites
37Competitive pharmacologic antagonist
Binds to target receptor
______ and ______ agonist
Decreases ______ of agonist
Increases agonist ____
does not affect agonist ____
competes and displaces
potency
EC50
Emax
38chemical antagonism
drug binds a chemical and prevents its action
39physioloic antagonism
two agonists produce opposite effects by actions on different receptors
40pharmacologic antagonism
drug acts on same receptor as an agonist and decreases agonist potency or efficacy
41additive or potentiating synergy
potentiation: agent with no efficacy alone increases the potency of an agonist